View Single Post
Old 01-23-2015, 09:13 PM   #6
'lizbeth
Senior Member
 
'lizbeth's Avatar
 
Join Date: Apr 2008
Location: Sunny San Diego
Posts: 2,214
Re: NeuVax reduces recurrence by 78.4% over 5 years

I did not participate in this trial as a patient. I have never received the Neuvax vaccine.

Since the vaccine is not currently approved for the general population Galena Biopharma is not making money on the vaccine. The company is following the clinical trial system to get FDA approval, Phase I - Phase III. I do agree it is a terrible system that patients must die to get a treatment approved. But this company did not create the clinical trial system and the vaccine won't be approved if they don't follow the FDA regulations.

Many women have benefited from participating. I am so happy for them.

I am and will continue to celebrate the progress of a vaccine that reduces the recurrence rate of Her2 positive breast cancer.

If you don't qualify for this clinical trial look for another. I have participated in 6 to advance cancer treatment.
__________________
Diagnosed 2007
Stage IIb Invasive Ductal Carcinoma, Pagets, 3 of 15 positive nodes

Traditional Treatment: Mastectomy and Axillary Node Dissection followed by Taxotere, 6 treatments and 1 year of Herceptin, no radiation
Former Chemo Ninja "Takizi Zukuchiri"

Additional treatments:
GP2 vaccine, San Antonio Med Ctr
Prescriptive Exercise for Cancer Patients
ENERGY Study, UCSD La Jolla

Reconstruction: TRAM flap, partial loss, Revision

The content of my posts are meant for informational purposes only. The medical information is intended for general information only and should not be used in any way to diagnose, treat, cure, or prevent disease
'lizbeth is offline